Effect of noninvasive ventilation on mortality and clinical outcomes among patients with severe hypoxemic COVID-19 pneumonia after high-flow nasal oxygen failure: a multicenter retrospective French cohort with propensity score analysis

Bibliographic Details
Title: Effect of noninvasive ventilation on mortality and clinical outcomes among patients with severe hypoxemic COVID-19 pneumonia after high-flow nasal oxygen failure: a multicenter retrospective French cohort with propensity score analysis
Authors: Antoine Goury, Zeyneb Houlla, Mathieu Jozwiak, Tomas Urbina, Matthieu Turpin, Alexandra Lavalard, Driss Laghlam, Sebastian Voicu, Jeremy Rosman, Claire Coutureau, Bruno Mourvillier
Source: Respiratory Research, Vol 25, Iss 1, Pp 1-10 (2024)
Publisher Information: BMC, 2024.
Publication Year: 2024
Collection: LCC:Diseases of the respiratory system
Subject Terms: COVID-19, Acute respiratory failure, Noninvasive ventilation, High flow oxygen therapy, Outcomes, Mortality, Diseases of the respiratory system, RC705-779
More Details: Abstract Background We assessed the effect of noninvasive ventilation (NIV) on mortality and length of stay after high flow nasal oxygenation (HFNO) failure among patients with severe hypoxemic COVID-19 pneumonia. Methods In this multicenter, retrospective study, we enrolled COVID-19 patients admitted in intensive care unit (ICU) for severe COVID-19 pneumonia with a HFNO failure from December 2020 to January 2022. The primary outcome was to compare the 90-day mortality between patients who required a straight intubation after HFNO failure and patients who received NIV after HFNO failure. Secondary outcomes included ICU and hospital length of stay. A propensity score analysis was performed to control for confounding factors between groups. Exploratory outcomes included a subgroup analysis for 90-day mortality. Results We included 461 patients with HFNO failure in the analysis, 233 patients in the straight intubation group and 228 in the NIV group. The 90-day mortality did not significantly differ between groups, 58/228 (25.4%) int the NIV group compared with 59/233 (25.3%) in the straight intubation group, with an adjusted hazard ratio (HR) after propensity score weighting of 0.82 [95%CI, 0.50–1.35] (p = 0.434). ICU length of stay was significantly shorter in the NIV group compared to the straight intubation group, 10.0 days [IQR, 7.0-19.8] versus 18.0 days [IQR,11.0–31.0] with a propensity score weighted HR of 1.77 [95%CI, 1.29–2.43] (p
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1465-993X
Relation: https://doaj.org/toc/1465-993X
DOI: 10.1186/s12931-024-02873-4
Access URL: https://doaj.org/article/46e67e19fa02488faf5116bc87215a7b
Accession Number: edsdoj.46e67e19fa02488faf5116bc87215a7b
Database: Directory of Open Access Journals
Full text is not displayed to guests.
More Details
ISSN:1465993X
DOI:10.1186/s12931-024-02873-4
Published in:Respiratory Research
Language:English